Navigation Links
2011 European Muldisciplinary Cancer Congress abstracts online Sept. 12
Date:9/8/2011

Europe's largest cancer congress, the 2011 European Multidisciplinary Cancer Congress [1], will be publishing the majority of the abstracts that are to be presented at the meeting in Stockholm (Sweden) online at midday on Monday 12 September. The congress takes place between Friday 23 September and Tuesday 27 September 2011.

Journalists will be able to report on these abstracts from the time they are published on Monday; however, you need to be aware that, as these abstracts were submitted earlier in the year, the data in some of them may have been updated since then and newer data may be presented at the congress in Stockholm.

Some abstracts will not be published online on Monday 12 September. These include all those that feature in the official congress media programme, all the late-breaking abstracts, and a few others, including those selected as "best" abstracts. These will be held back and only published on the day that they are to be presented at the meeting. They will be embargoed to the day of presentation. For more precise information on the exact timing of these embargoes and information about the official media programme at the congress, please contact Emma Mason, Mary Rice or Lisa Lnner Pulkkinen (for Swedish journalists) contact details below.

The abstracts can be found from 1200 hrs CEST on Monday 12 September at: http://stockholm2011.ecco-org.eu/programmesearch

There will be over 2,000 presentations at the 2011 European Multidisciplinary Cancer Congress, and around 16,000 participants from 120 countries are expected to attend the meeting. It is the only cancer congress in Europe to offer presentations of cutting-edge research across the whole cancer field, and will include basic and translational research, first reports from high quality phase II and III clinical trials, epidemiology and much more.


'/>"/>

Contact: Mary Rice
mary.rice@riceconseil.eu
ECCO-the European CanCer Organisation
Source:Eurekalert

Page: 1

Related medicine news :

1. Your e-Marketing Journey in 2010: An e-Book for Corporate Communicators Working in European Headquarters
2. United Therapeutics Corporation Withdraws European Marketing Authorization Application for Tyvaso for the Treatment of Pulmonary Arterial Hypertension
3. International Collaboration: FDA and European Medicines Agency Agree to Accept a Single Orphan Drug Designation Annual Report
4. Yondelis(R) Receives Five New Approvals Outside the European Economic Area
5. Promega Maxwell 16 IVD System CE Marked to the European Union IVD Directive Delivers Combined Solution for Infectious Disease
6. The European Medicines Agency Completes Validation Stage for InterMunes Marketing Authorization Application for pirfenidone
7. European hematologist receives award to conduct research in US
8. European collaboration seeks to create World Wide Web for robots
9. HCL Thames Medics says more locum doctors could help address European Working Time Directive shortage
10. Third European Novel Food Approval Received by Tahitian Noni International
11. European Urology: Editorial about REDUCE trial underlines value of dutasteride
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... 2016 , ... Experts from the American Institutes for Research ... June 26-28, 2016, at the Hynes Convention Center in Boston. , AIR experts ... planning, healthcare costs and patient and family engagement. , AIR researchers will be ...
(Date:6/25/2016)... ... ... of Bruton Memorial Library on June 21 due to a possible lice infestation, as reported ... head lice: the parasite’s ability to live away from a human host, and to infest ... in the event that lice have simply gotten out of control. , As lice are ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room , the largest ... as the Medical Director of its new Mesquite-Samuell Farm facility. , “We are ... Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin ... injury. Recently, he has implemented orthobiologic procedures as a method for treating his ... of the first doctors to perform the treatment. Orthobiologics are substances that orthopaedic ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits ... terms of the latter, setting the bar too high can result in disappointment, perhaps ... slow progress toward their goal. , Research from PsychTests.com reveals that ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... , June 26, 2016 One of Australia,s ... announced the formation of a new biotechnology company, Noxopharm Limited [ABN ... in an IPO and to list on the ASX. ... NOX66, ready to enter a Phase 1 clinical study later this ... to address one of the biggest problems facing cancer patients - ...
(Date:6/26/2016)... -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ ) ... Improvements Act of 1976, as amended ("HSR"), with respect ... Nasdaq: CPXX ) expired effective June 24, ... As previously announced on May 31, 2016, Jazz Pharmaceuticals ... which Jazz Pharmaceuticals has commenced a tender offer for ...
(Date:6/26/2016)... , June 27, 2016  VMS Rehab Systems, Inc. ... will take whatever measures required to build a strong ... which is currently listed on the OTC Markets-pink current ... Chairman and CEO, "We are seeing an anomaly in ... understand, not only by the Company, but shareholders and ...
Breaking Medicine Technology: